The global PD-L1 biomarker testing market size was valued at US$ 541.6 Mn in 2021 and is expected to exhibit a CAGR of close to 9.4% over the forecast period (2022-2032). Increasing incidence of cancer across the globe is underpinning the need for advanced cancer diagnosis equipment, which is expected to boost the market in the forthcoming years. Cancer immunotherapy is …
Continue reading “PD-L1 Biomarker Testing Market Is Expected to reach USD 1.46 Bn by 2032 | FMI”